Tomicide, 90 ml

Skin infections, Angina, Trophic ulcers, Varicose veins, Purulent wounds, Pyoderma

Tomicid is designed to treat infections caused by Gram-positive cocci (angina, pyoderma, suppuration of wounds, as well as for the prevention of postoperative wound suppuration).

The drug can be used in association of Gram-positive cocci with other pathogens.

Indications

Tomicide is intended for the treatment of infections caused by gram-positive cocci (angina, pyoderma, suppuration of wounds, as well as for the prevention of suppuration of postoperative wounds).

The drug can be used in cases of association of gram-positive cocci with other pathogens.

Pharmacological effect

Tomicide has a bactericidal effect against gram-positive cocci.

Active ingredient

Non-pathogenic streptococcus – Streptococcus

Composition

A sterile product of the metabolism of non-pathogenic streptococcus, greenish-yellow in color, transparent, without opalescence and foreign bodies, with a sour taste.

Contraindications

There are no contraindications to the use of tomicide.

Side Effects

When tomicide is applied to the affected area of ​​the skin, a short-term burning sensation may occur.

Storage conditions

In a dry place, protected from light, at a temperature of 2° to 10°C

Shelf life

2 years

Manufacturer

Biomed named after I.I.Mechnikova JSC, Russia